IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.
Han, Guohong1; Yang, Jijin1; Shao, Guoliang1; Teng, Gaojun1; Wang, Maoqiang1; Yang, Jianyong1; Liu, Zhaoyu1; Feng, Gansheng1; Yang, Renjie1; Lu, Ligong1; Chao, Yee1; Wang, Jianhua1
刊名JOURNAL OF CLINICAL ONCOLOGY
2012-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000318009804831
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/49942
专题北京大学临床肿瘤学院
作者单位1.Second Mil Med Univ, Changhai Hospitai, Shanghai, Peoples R China
2.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
3.Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China
4.Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
5.Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China
6.China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
7.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China
8.Peking Univ, Beijing Canc Hosp, Beijing 100871, Peoples R China
9.Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
10.Taipei Vet Gen Hosp, Taipei, Taiwan
11.Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
推荐引用方式
GB/T 7714
Han, Guohong,Yang, Jijin,Shao, Guoliang,et al. Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2012,suppl.S(15).
APA Han, Guohong.,Yang, Jijin.,Shao, Guoliang.,Teng, Gaojun.,Wang, Maoqiang.,...&Wang, Jianhua.(2012).Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial..JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Han, Guohong,et al."Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2012).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Han, Guohong]的文章
[Yang, Jijin]的文章
[Shao, Guoliang]的文章
百度学术
百度学术中相似的文章
[Han, Guohong]的文章
[Yang, Jijin]的文章
[Shao, Guoliang]的文章
必应学术
必应学术中相似的文章
[Han, Guohong]的文章
[Yang, Jijin]的文章
[Shao, Guoliang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。